SF3B1 and chronic myelomonocytic leukemia: From a clinical point of view, CMML patients with SF3B1 mutations show a lower white blood-cell count and low lymphocyte count respective to wild-type counterparts; however, this genotype does not seem to be associated with acute leukemic progression or to affect the overall survival [46,49].